The importance of underlying disease in patients with gram-negative bacteremia.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000453:epidemiology*; D004352:Drug Resistance, Microbial; D004927:Escherichia coli Infections / Q000188:drug therapy*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000453:epidemiology; D011512:Proteus Infections / Q000188:drug therapy* / Q000453:epidemiology; D011552:Pseudomonas Infections / Q000188:drug therapy*; D012189:Retrospective Studies
D000900:Anti-Bacterial Agents